APA (7th ed.) Citation

Han, X., Zhou, H., Sun, W., Hou, L., Wang, Y., Wang, H., . . . Xue, X. (2023). IDH1R132H mutation increases radiotherapy efficacy and a 4-gene radiotherapy-related signature of WHO grade 4 gliomas. Scientific Reports, 13(1), 1. https://doi.org/10.1038/s41598-023-46335-1

Chicago Style (17th ed.) Citation

Han, Xuetao, Huandi Zhou, Wei Sun, Liubing Hou, Yanqiang Wang, Hong Wang, Zhongqiang Lv, and Xiaoying Xue. "IDH1R132H Mutation Increases Radiotherapy Efficacy and a 4-gene Radiotherapy-related Signature of WHO Grade 4 Gliomas." Scientific Reports 13, no. 1 (2023): 1. https://doi.org/10.1038/s41598-023-46335-1.

MLA (9th ed.) Citation

Han, Xuetao, et al. "IDH1R132H Mutation Increases Radiotherapy Efficacy and a 4-gene Radiotherapy-related Signature of WHO Grade 4 Gliomas." Scientific Reports, vol. 13, no. 1, 2023, p. 1, https://doi.org/10.1038/s41598-023-46335-1.